Search for Alnylam Gets Some Welcome News on Bing

newsfeedback@fool.com (Todd Campbell), The Motley Fool
Fri, 12/15/2017 - 1:00pm

The FDA has agreed to allow Alnylam (NASDAQ: ALNY) and Sanofi (NYSE: SNY) to resume trials of their hemophilia therapy, fitusiran. Previously, these companies had to halt their fitusiran studies after a patient who had advanced into an extension study died because of a fatal blood clot. Is this news good for patients and investors?Hemophilia A is caused by a deficiency of blood coagulation factor VIII and hemophilia B is caused by a deficiency of blood coagulation factor IX.

PREV NEXT
Topics:  fda   alnylam nasdaq   alny    sanofi nyse   sny    hemophilia a   viii   ix in   images   a   news   blood   deficiency   
BING NEWS:
  • The Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) First-Quarter Results Are Out And Analysts Have Published New Forecasts
    Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) just released its latest first-quarter results and things are looking bullish. The results overall were pretty good, with revenues of US$494m exceeding ...
    05/5/2024 - 1:48 am | View Link
  • Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
    Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75. ALNY isn’t one of the 30 most popular ...
    05/3/2024 - 6:01 am | View Link
  • Strong Financial Growth and Promising Clinical Trials Bolster Buy Rating for Alnylam Pharmaceuticals
    Alnylam Pharma (ALNY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Keay Nakae from Chardan Capital reiterated a Buy rating on the stock ...
    05/2/2024 - 9:43 pm | View Link
  • Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
    Alnylam Pharmaceuticals Inc ( NASDAQ:ALNY) showcases robust revenue growth with a 54.8% increase in total revenues year-over-year. Despite increased revenues, ALNY faces a net loss, highlighting the ...
    05/2/2024 - 6:07 pm | View Link
  • Alnylam Pharmaceuticals
    Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...
    05/2/2024 - 1:00 pm | View Link
  • More
BING SEARCH:
  • Press Releases | Alnylam Pharmaceuticals, Inc.
    Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity. Jan 29, 2024. Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results. Jan 09, 2024.
    05/4/2024 - 5:28 pm | View Website
  • Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price & News
    Get the latest Alnylam Pharmaceuticals, Inc. (ALNY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
    05/4/2024 - 10:11 am | View Website
  • Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global ...
    Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates. Business Wire. Sun, Jan 7, 2024, 6:00 PM 8 min read.
    05/4/2024 - 7:05 am | View Website
  • Alnylam® Pharmaceuticals
    THE LEADING RNAi THERAPEUTICS COMPANY. Alnylam has led the translation of RNA interference (RNAi) from Nobel Prize-winning discovery into an entirely new class of medicines, which we believe has the potential to help people all over the world to live longer, healthier, and fuller lives.
    05/4/2024 - 4:13 am | View Website
  • Alnylam Pharmaceuticals
    Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
    05/4/2024 - 12:24 am | View Website
  • More
PREV NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News